21688 results

Abdon Avila Chavez

Mexico City, Mexico

Lely Puspita Candra Dewi

Malang, Indonesia

Nicholas Chew

Singapore, Singapore

Bryan Chong

Singapore, Singapore

Helena Correia

Lisboa, Portugal

Keuffel Dangazo

Cebu, Philippines

Kristy Garganera

Metro Manila, Philippines

Percutaneous myocardial revascularization in late-presenting patients with STEMI

30 Sep 2021

Through this registry-based analysis, the authors sought to assess short and long-term outcomes of revascularisation in a latecomer STEMI population presenting between 12 to 48 hours of symptom onset.

Reviewer

Aaysha Cader

Reviewer

Saidur Rahman Khan

Syed Haque

Mumbai, India

Fani Suslina Hasibuan

Tuban, Indonesia

Treating complex coronary lesions: right case right time Prevail™ DCB

01 Oct 2021 – From AICT-AsiaPCR 2021

Thanks to this session, find out more about indications for drug-coated balloons, or, on the contrary, learn when not to use it. And through the analysis of two concrete cases, see how DCB can be an important tool to tackle increasingly complex patients and anatomies, especially...

Jieli Kua

Singapore, Singapore

Tjen Jhung Lee

Kuala Lumpur, Malaysia

Telescope guide extension catheter in complex coronary interventions

01 Oct 2021 – From AICT-AsiaPCR 2021

View the complex case of this 70-year-old male patient with hypertension and diabetes who presented with chest pain and NSTEMI, which shows that, when dealing with challenging calcific disease, guide catheter extensions help improve device delivery.

Ki Fung Cliff Li

Singapore, Singapore

Najmiddin Makhkamov

Tashkent, Uzbekistan

MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

01 Oct 2021 – From AICT-AsiaPCR 2021

In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.

Wee Meng Ng

Singapore, Singapore

Jonathan Ong

Singapore, Singapore

Renal denervation in the real-world: performance in high risk subgroups

05 Oct 2021 – From AICT-AsiaPCR 2021

After having evoked in particular the SPRAL HTN Global Clinical Program, the RDN consensus statements, the EHS position paper 2021, the ARDeC, and the STEP Trial, Tzung-Dau Wang shares his experience in using renal denervation to manage uncontrolled hypertension by illustrating his words with the case...